Part one of this three-part series examines the rational for using control technology to reduce process variability ...

Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.

David T. Johnson reported, "we incurred an expense in the third quarter of 2025 related to the product liability claims," and ...

Mativ Holdings, Inc. (NYSE: MATV) Q3 2025 Earnings Call Transcript November 6, 2025 ...

Airports around the world are taking the pain out of travel as they compete to become global hubs. Canadian airports, however ...

Some organisations don’t fail because they lack ideas. In fact, this is true for many startups. They fail because they are ...

Scaling a services business involves more than increasing client volume. It requires building a stable operational base, ...

The 54 winning counties in this year’s survey are incorporating community feedback into their plans, ensuring responsible AI use, maturing their data programs and navigating challenges without ...

Data-defined bioprocesses enable real-time data flow seamlessly across AI continually optimizing operations, while making ...

P3 Health Partners Inc. (NASDAQ: PIII) Q3 2025 Earnings Call Transcript November 14, 2025 P3 Health Partners Inc. misses on ...

Net Loss -- Net loss for Q3 2025 was $2.3 million compared to a $6.9 million loss in Q3 2024, driven by higher gross profit, reduced operating expenses, and partially offset by higher interest expense ...